Overview

Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies

Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a single-center, open label, non randomized, compassionate use protocol in patients with advanced solid tumor malignancies who were previously enrolled in the phase I study (NCT00878189) of this agent.
Details
Lead Sponsor:
University of Colorado, Denver
Collaborators:
Pfizer
SpringWorks Therapeutics, Inc.